Preventive care in the emergency department: Should emergency departments conduct routine HIV screening? A systematic review

Academic Emergency Medicine

Volumn 10, Issue 3, 2003, Pages 278-285

  Rothman, Richard E ^a   Ketlogetswe, Kerunne S ^a   Dolan, Teresa ^b   Wyer, Peter C ^c   Kelen, Gabor D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Emergency department; Emergency services; High risk behavior; HIV screening; Preventive services

Indexed keywords

ARTICLE; BEHAVIOR; COST BENEFIT ANALYSIS; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; HIGH RISK PATIENT; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SCREENING; SEROPREVALENCE; SEXUAL BEHAVIOR;

AIDS SERODIAGNOSIS; COST-BENEFIT ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; EMERGENCY SERVICE, HOSPITAL; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS;

EID: 0037334681     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.10.3.278     Document Type: Article

References (38)

1. Rhodes KV, Gordon JA, Lowe RA. Preventive care in the emergency department, part I: clinical preventive services - are they relevant to emergency medicine? Acad Emerg Med. 2000; 7:1036-41.
2. Irvin CB, Wyer PC, Gerson LW. Preventive care in the emergency department, part II: clinical preventive services - an emergency medicine evidence-based review. Acad Emerg Med. 2000; 7:1042-54.
3. Centers for Disease Control and Prevention. CDC guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR. 1999; 48(RR-13):1-31.
4. Centers for Disease Control and Prevention. HIV and AIDSUnited States, 1981-2000. MMWR. 2001; 50:430-4.
5. Karon JM, Flemin PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health. 2001; 91:1060-8.
6. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, Second Edition. Washington, DC: U.S. Department of Health and Human Services, 1996.
7. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994; 331:1173-80.
8. Sande MA, Carpenter CCJ, Cobbs CG, Holmes KK, Sanford JP. Antiretroviral therapy for adult HIV-infected patients. JAMA. 1993; 270:2583-9.
9. Lundgren JD, Philllips AN, Pedersen C, et al. Comparison of long-prognosis of patients with AIDS treated and not treated with zidovudine. JAMA. 1994; 271:1088-92.
10. Kamenga M, Ryder RW, Jingu M, et al. Evidence of marked sexual behavior change associated with low HIV-1 serocon-version in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counseling center in Zaire. AIDS. 1991; 5:61-7.
11. Padian NS, O'Brien TR, Chang YC, Glass S, Francis DP. Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr. 1993; 6:1043-8.
12. Wenger NS, Greenberg JM, Hilborne LH, Kusseling F, Mangotich M, Shapiro MF. Effect of HIV antibody testing and AIDS education on communication about HIV risk and sexual behavior. Ann Intern Med. 1992; 117:905-11.
13. McCarthy BD, Wong JB, Munoz A. Who should be screened for HIV? Arch Intern Med. 1993; 153:1107-16.
14. Holtgrave DR, Valdiserri RO, Gerber AR, Hinman AR. Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. Arch Intern Med. 1993; 153:1225-30.
15. Hirschel B, Lazzarin A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med. 1991; 324:1079-83.
16. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993; 342:268-72.
17. Centers for Disease Control and Prevention. Recommendations for HIV testing sevices in inpatients and outpatients in acute-care hospital settings. MMWR. 1993; 42(RR-2):1-6.
18. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUORUM statement. Lancet. 1999; 354:1896-900.
19. The Cochrane Collaboration Handbook, The Cochrane Library Version 3.0.2. Oxford, UK: Update Software, 1997.
20. Briss PA, Zaza S, Pappaioanou M, et al. Developing an evidence-based guide to community preventive services - Methods. Am J Prev Med. 2000; 18(1 suppl):35-43.
21. Schoenbaum EE, Mayris PW. The underrecognition of HIV infection in women in an inner-city emergency room. Am J Public Health. 1993; 83:363-8.
22. Lindsay MK, Grant J, Peterson HB, Risby J, Williams H, Klein L. Human immunodeficiency virus infection among patients in a gynecology emergency department. Obstet Gynecol. 1993; 81:1012-5.
23. Kelen GD, Hexter DA, Hansen KA, Tang N, Pretorius S, Quinn TC. Trends in human immunodeficiency virus (HIV) infection among a patient population of an inner-city emergency department: implications for emergency department-based screening programs for HIV infection. Clin Infect Dis. 1995; 21:867-75.
24. Kelen GD, Hexter DA, Hansen KN, et al. Feasibility of an emergency department-based, risk-targeted voluntary HIV screening program. Ann Emerg Med. 1996; 27:687-92.
25. Alpert PL, Shuter J, DeShaw MG, Webber MP, Klein RS. Factors associated with unrecognized HIV-1 infection in an inner-city emergency department. Ann Emerg Med. 1996; 28:159-64.
26. Famham PG, Gorsky RD, Holtgrave DR, et al. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Rep. 1996; 3:44-53.
27. La Croix SJ, Russo G. A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients. Soc Sci Med. 1996; 42:1259-72.
28. Kelen GD, Shahan JB, Quinn TC. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med. 1999; 33: 147-55.
29. Goggin MA, Davidson AJ, Cantrill SV, O'Keefe LK, Douglas JM. The extent of undiagnosed HIV infection among emergency department patients: results of a blinded seroprevalence survey and a pilot HIV testing program. J Emerg Med. 2000; 19:13-9.
30. Weinstock H, Dale M, Linley L, Gwinn M. Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health. 2002; 92:280-3.
31. Centers for Disease Control and Prevention. Publicly funded HIV counseling and testing: United States. MMWR. 1991; 20:730-3.
32. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR. 2001; 50(RR-19):1-53.
33. Stern RS, Weissman JS, Epstein AM. The emergency department as a pathway to admission for poor and high-cost patients. JAMA. 1991; 266:2238-43.
34. Centers for Disease Control and Prevention. HIV prevalence trends in selected populations in the United States: results from national serosurveillance, 1993-1997. Atlanta: CDC, 2001, pp 1-51.
35. Williams M, Bowen A, Ross M, Freeman R, Elwood W. Perceived compliance with AZT dosing among a sample of African-American drug users. Int J STD AIDS. 2000; 11:57-63.
36. Clarke SM, Mulcahy FM. Antiretroviral therapy for drug users. Int J STD AIDS. 2000; 11:627-31.
37. Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA. 1998; 280:567-8.
38. Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent-care clinic - Atlanta, GA. MMWR. 2001; 50(25):538-41.